Gregory Henry Dostal, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3225 Hospital Dr, #102, Juneau, AK 99801 Phone: 907-586-3068 Fax: 907-586-3078 |
News Archive
Researchers at the Allen Institute for Brain Science have found that the same genes have different activity patterns in the brain in individuals with different genetic backgrounds. These findings may help to explain individual differences in the effectiveness and side-effect profiles of therapeutic drugs and thus have implications for personalized medicine. The study is available in this week's online early edition of the Proceedings of the National Academy of Sciences (www.pnas.org).
A series of studies published in the September Journal of Nuclear Medicine (JNM) show that molecular imaging plays a critical role in the evaluation and treatment planning for a broad spectrum of cancers, including thyroid cancer and lymphoma.
Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that principal investigator, Srdan Verstovsek, MD, PhD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 2, 2014 at the American Society for Clinical Oncology 2014 Annual Meeting.
A new slow-release vaccine has been shown to boost the immune system's response to the HIV virus. The vaccine is given in small doses over a period of days, compared to one large dose.
› Verified 7 days ago